603538.SS · 美诺华
China A-shares · RS rating 31 · As of 2026-10-14
| Price | 24.17 CNY |
|---|---|
| 1-day change | -5.0% |
| RS rating (overall / 1M / 3M / 12M) | 31 / 24 / 27 / 76 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 33 / 22 / 12 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +54.4% |
| Distance from 52-week high | +64.7% |
| Market cap (USD) | $1.5B |